Nomura Holdings’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Nomura Holdings’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10	Closed	–	–	2716
2013 Q2	$0	Buy	+10	New	+$184	﹤0.01%	2264

Other funds holding IPCI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

FNYS

First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Nomura Holdings's IPCI Position: Q3 2013 in Review

Nomura Holdings sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2013, closing a stake of 10 shares.

Nomura Holdings first reported a position in IPCI in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 12 funds tracked by Wall St. Rank hold IPCI as of Q3 2013.

Nomura Holdings reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2013 after selling out during the quarter.
Nomura Holdings sold 10 Intellipharmaceuticals International Inc. shares in Q3 2013.
Nomura Holdings first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 1 quarter.
Nomura Holdings's Intellipharmaceuticals International Inc. position peaked at $0 in Q2 2013.
12 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2013.

Based on Nomura Holdings's 13F filing for Q3 2013, filed 14 Nov 2013.